Literature DB >> 4082999

Extraskeletal Ewing's sarcoma. A clinicopathologic and electron microscopic. Analysis of 8 cases.

H Hashimoto, M Tsuneyoshi, Y Daimaru, M Enjoji.   

Abstract

This clinicopathologic study concerns 8 cases of extraskeletal Ewing's sarcoma, including electron-microscopic examination of one case. In three patients, autopsy was done. The age of the patients ranged from 12 to 31 years with a median of 16 years. The tumors mainly arose in the soft tissues of the trunk (4 cases) and the lower extremity (3 cases). Histologically, they were made up of closely packed uniform, small cells, arranged in sheets separated by strands of fibrovascular stroma. The tumor cells had round to oval nuclei with finely dispersed chromatin and scanty ill-defined cytoplasm almost invariably containing a fair amount of diastase-digested PAS-positive material. Ultrastructurally, the tumor cells were composed principally of undifferentiated mesenchymal cells, and contained prominent pools of glycogen in the cytoplasm. Aggregates of intermediate filaments were seen in a perinuclear location. These light- and electron-microscopic findings are indistinguishable from those of Ewing's sarcoma of the bone. Differential points from other soft-tissue small round cell sarcomas such as malignant neuroepithelioma (peripheral neuroblastoma), embryonal or alveolar rhabdomyosarcoma were briefly discussed.

Entities:  

Mesh:

Year:  1985        PMID: 4082999

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  2 in total

1.  Orthopaedic case of the month: A 14-year-old boy with a medial thigh soft tissue mass.

Authors:  David A Ibrahim; Leo Mascarenhas; Jason P Tovar; Alexandre Arkader
Journal:  Clin Orthop Relat Res       Date:  2013-05       Impact factor: 4.176

2.  A single institution experience of combined modality management of extra skeletal Ewings sarcoma.

Authors:  Ramachandran Venkitaraman; Mathew K George; S Ganapathy Ramanan; T G Sagar
Journal:  World J Surg Oncol       Date:  2007-01-11       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.